Abingdon Health (Abingdon Health) EV-to-EBIT : -5.67 (As of May. 26, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Abingdon Health EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Abingdon Health's Enterprise Value is $16.44 Mil. Abingdon Health's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-2.90 Mil. Therefore, Abingdon Health's EV-to-EBIT for today is -5.67.

The historical rank and industry rank for Abingdon Health's EV-to-EBIT or its related term are showing as below:

ABDXF' s EV-to-EBIT Range Over the Past 10 Years
Min: -30.61 Med: -7.48 Max: -0.46
Current: -5.5

During the past 6 years, the highest EV-to-EBIT of Abingdon Health was -0.46. The lowest was -30.61. And the median was -7.48.

ABDXF's EV-to-EBIT is ranked worse than
100% of 103 companies
in the Medical Diagnostics & Research industry
Industry Median: 21.9 vs ABDXF: -5.50

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Abingdon Health's Enterprise Value for the quarter that ended in Dec. 2023 was $7.27 Mil. Abingdon Health's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-2.90 Mil. Abingdon Health's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -39.92%.

Abingdon Health EV-to-EBIT Historical Data

The historical data trend for Abingdon Health's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abingdon Health EV-to-EBIT Chart

Abingdon Health Annual Data

Trend

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

EV-to-EBIT

Get a 7-Day Free Trial

-6.46

-0.57

-3.56

Abingdon Health Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial					-	-0.57	-	-3.56	-

Competitive Comparison of Abingdon Health's EV-to-EBIT

For the Diagnostics & Research subindustry, Abingdon Health's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Abingdon Health's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Abingdon Health's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Abingdon Health's EV-to-EBIT falls into.

Abingdon Health EV-to-EBIT Calculation

Abingdon Health's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	16.436	/	-2.901
	=	-5.67

Abingdon Health's current Enterprise Value is $16.44 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Abingdon Health's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-2.90 Mil.

Abingdon Health (OTCPK:ABDXF) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Abingdon Health's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 )	=	EBIT	/	Enterprise Value (Q: Dec. 2023 )
	=	-2.901	/	7.26719
	=	-39.92 %

Abingdon Health's Enterprise Value for the quarter that ended in Dec. 2023 was $7.27 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Abingdon Health's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-2.90 Mil.

Abingdon Health EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Abingdon Health's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Abingdon Health (Abingdon Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Abingdon Health PLC (OTCPK:ABDXF) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

ABDX:UK

Address

York Biotech Campus, Sand Hutton, York, GBR, YO41 1LZ

Website

https://www.abingdonhealth.com

Abingdon Health PLC is a technology-enabled lateral flow diagnostics company. It provides rapid testing solutions to clients in healthcare and other industries. The firm's product ABC-19 is an antibody test for Covid-19 , and also produces tests covering areas such as self-test HIV, equine infection, human fertility, etc. Business operating segments includes; Contract Development comprises development work for third parties. Contract Manufacturing comprises contract development and manufacturing activities. Product Sales comprises the sale of ABC-19, Pocket Diagnostic products, PCRD tests and antibodies for research use. Key revenue comes from Contract Development segment. Geographically it operates and earns revenue from the UK, USA and Canada, Europe and the rest of the world.

Abingdon Health (Abingdon Health) Headlines

From GuruFocus

AbC-19� Rapid Test Available for Purchase by Healthcare Professionals

By Business Wire Business Wire • 02-16-2021